Warning letters: Investigators refused entry to testing lab; firm cited for distributing unauthorized COVID tests

Regulatory News

Regulatory NewsJoanne S. Eglovitch

Audit/inspectionComplianceMedical DevicesNorth AmericaPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/Policy